Brexit update

Posted Sep 26 2019 in News from Epilepsy Research UK

ERUK and the Association of Medical Research Charities are continuing to monitor events and engage with key stakeholders and the Government on Brexit.

Last month, Epilepsy Research UK joined a coalition of charities led by SUDEP Action to call for the Government to publish the medicines sections of their No-Deal Brexit ‘Yellowhammer’ papers. Acknowledgement has been received from 10 Downing Street in response to the epilepsy coalition’s open letter calling for urgent action to prevent Brexit-related epilepsy deaths.

The updated NHS guidance for getting your medicines in the event of a ‘No-Deal’ Brexit is here.

Urgent action is required to mitigate shortages of medications and disruptions to supply, which could pose a heightened risk for people living with epilepsy. The coalition has flagged this as an urgent concern and called for patient safety to be central to all plans.


News categories